OTC:MGROF

MustGrow Biologics (MGROF) Stock Price, News & Analysis

C$0.74
-0.05 (-6.33%)
(As of 04/26/2024 ET)
Today's Range
C$0.73
C$0.81
50-Day Range
C$0.77
C$1.04
52-Week Range
C$0.57
C$1.81
Volume
212,536 shs
Average Volume
6,820 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
MGROF stock logo

About MustGrow Biologics Stock (OTC:MGROF)

MustGrow Biologics Corp., an agricultural biotech company, focuses on development and commercialization of natural biopesticides, biofumigants, and bioherbicides derived from mustard seed. It provides preplant soil biofumigation, a technology to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and other crops; and TerraMG, a mustard-derived soil biopesticide technology for use as a preplant soil biopesticide for soil-borne diseases and pests for various crops, such as fruits & vegetables, bananas, canola, and pulses. The company is also developing bioherbicide to treat unwanted plant growth for use in organic agriculture, home, and garden markets, as well as agriculture markets; and postharvest food preservation, an application in sprout, disease, and pathogen treatment for storage and food preservation markets. The company was formerly known as Duport Capital Ltd. and changed its name to MustGrow Biologics Corp. in March 2018. MustGrow Biologics Corp. was incorporated in 2014 and is headquartered in Saskatoon, Canada.

MGROF Stock Price History

MGROF Stock News Headlines

MustGrow Biologics (OTC:MGROF) Shares Down 5.1%
The Next Step of Their Control Is Here …
Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.
MustGrow Biologics Corp. (MGROF)
The Next Step of Their Control Is Here …
Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.
AbCellera Biologics Inc Ordinary Shares ABCL
See More Headlines
Receive MGROF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MustGrow Biologics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/26/2024
Next Earnings (Estimated)
4/27/2024

Industry, Sector and Symbol

Industry
Agricultural Inputs
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

  • Mr. Corey J. Giasson B.Sc. (Age 46)
    MBA, President, CEO & Director
    Comp: $212.04k
  • Mr. Todd L. Lahti CA (Age 58)
    CFA, CFO & Corporate Secretary
    Comp: $194.37k
  • Mr. Colin Bletsky
    COO & Director

MGROF Stock Analysis - Frequently Asked Questions

How have MGROF shares performed in 2024?

MustGrow Biologics' stock was trading at C$0.97 at the start of the year. Since then, MGROF stock has decreased by 23.7% and is now trading at C$0.74.
View the best growth stocks for 2024 here
.

When is MustGrow Biologics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Saturday, April 27th 2024.
View our MGROF earnings forecast
.

How do I buy shares of MustGrow Biologics?

Shares of MGROF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTC:MGROF) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners